Veltio Pharma Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $343K

  • Investors
  • 2

Veltio Pharma General Information

Description

Developer of proprietary nanotechnology platform designed to improve the solid oral dosage of medicines. The company's platform specializes in reviving industrial projects where the solubility of the active substance has been problematic and current approaches have been deemed insufficient, providing drug suppliers with a platform to reformulate generic drugs and improve their bioavailability and cost-efficiency.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Care of Folkesson
  • Dragarbrunnsgatan 78B
  • 750 03 Uppsala
  • Sweden
Primary Industry
Biotechnology
Corporate Office
  • Care of Folkesson
  • Dragarbrunnsgatan 78B
  • 750 03 Uppsala
  • Sweden

Veltio Pharma Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Veltio Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 01-Jan-2024 $343K Completed Generating Revenue
2. Later Stage VC 01-Jan-2023 Completed Generating Revenue
1. Early Stage VC 17-Mar-2022 $385K $385K Completed Generating Revenue
To view Veltio Pharma’s complete valuation and funding history, request access »

Veltio Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preference
Preference
Preference 20,600 $17.54 $17.54 1x $17.54 18.38%
To view Veltio Pharma’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Veltio Pharma Patents

Veltio Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202507755-D0 New compositions Pending 19-May-2025
EP-3413873-A1 New compositions Active 12-Feb-2016
EP-3413873-B1 New compositions Active 12-Feb-2016
EP-3413873-C0 New compositions Active 12-Feb-2016
ES-2971977-T3 New compositions Active 12-Feb-2016 A61K9/146
To view Veltio Pharma’s complete patent history, request access »

Veltio Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Veltio Pharma Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Almi Invest Venture Capital Minority
Paab Venture Capital Minority
To view Veltio Pharma’s complete investors history, request access »

Veltio Pharma FAQs

  • When was Veltio Pharma founded?

    Veltio Pharma was founded in 2018.

  • Where is Veltio Pharma headquartered?

    Veltio Pharma is headquartered in Uppsala, Sweden.

  • What is the size of Veltio Pharma?

    Veltio Pharma has 6 total employees.

  • What industry is Veltio Pharma in?

    Veltio Pharma’s primary industry is Biotechnology.

  • Is Veltio Pharma a private or public company?

    Veltio Pharma is a Private company.

  • What is the current valuation of Veltio Pharma?

    The current valuation of Veltio Pharma is .

  • What is Veltio Pharma’s current revenue?

    The current revenue for Veltio Pharma is .

  • How much funding has Veltio Pharma raised over time?

    Veltio Pharma has raised $1.02M.

  • Who are Veltio Pharma’s investors?

    Almi Invest and Paab have invested in Veltio Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process